{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:37:45Z","timestamp":1793813865354,"version":"4.6.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Polycystic Ovary syndrome (PCOS) affects the health of many women around the world. Apart from fundamental metabolic problems connected to PCOS, focus of our study is on the role of quercetin on genes relevant to steroidogenesis and folliculogenesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eighteen mature parkes strain mice (4-5 weeks old) weighing 18\u201321 g were randomly divided into three groups of six each as follows: Group I serves as the control and was given water and a regular chow diet <jats:italic>ad lib<\/jats:italic> for 66 days; group II was given oral gavage administration of letrozole (LETZ) (6 mg\/kg bw) for 21 days to induce PCOS and was left untreated for 45 days; For three weeks, Group III received oral gavage dose of LETZ (6 mg\/kg), after which it received Quercetin (QUER) (125 mg\/kg bw orally daily) for 45 days.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In our study we observed that mice with PCOS had irregular estrous cycle with increased LH\/FSH ratio, decreased estrogen level and decline in expression of <jats:italic>Kitl<\/jats:italic>, <jats:italic>Bmp1<\/jats:italic>, <jats:italic>Cyp11a1<\/jats:italic>, <jats:italic>Cyp19a1<\/jats:italic>, <jats:italic>Ar<\/jats:italic>, <jats:italic>lhr<\/jats:italic>, <jats:italic>Fshr<\/jats:italic> and <jats:italic>Esr1<\/jats:italic> in ovary. Moreover, we observed increase in the expression of <jats:italic>CYP17a1<\/jats:italic>, as well as increase in cholesterol, triglycerides, testosterone, vascular endothelial growth factor VEGF and insulin levels. All these changes were reversed after the administration of quercetin in PCOS mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Quercetin treatment reversed the molecular, functional and morphological abnormalities brought on due to letrozole in pathological and physiological setting, particularly the issues of reproduction connected to PCOS. Quercetin doesn\u2019t act locally only but it acts systematically as it works on Pituitary (LH\/FSH)- Ovary (gonad hormones) axis. the Side effects of Quercetin have to be targeted in future researches. Quercetin may act as a promising candidate for medical management of human PCOS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1153289","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T15:45:23Z","timestamp":1692632723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Effect of quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Mohd Zahoor ul haq","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinoy kumar","family":"Shrivastva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manzoor Ahmad","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajid Mohammad","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Ashraf","family":"Ganie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulzar Ahmed","family":"Rather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Showkeen Muzamil","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Azam","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meneerah A.","family":"Al-Jafary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalelgadir Musa","family":"Homeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtesam A.","family":"Al-Suhaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2022.10.009","article-title":"Gallic Acid reverses ovarian disturbances in mice with letrozole-induced PCOS via modulating adipo R1 expression","volume":"9","author":"Ul Haq Shah","year":"2022","journal-title":"Toxicol Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1089\/met.2010.0039","article-title":"Polycystic ovary syndrome in the pediatric population","volume":"8","author":"Bremer","year":"2010","journal-title":"Metab Syndr Relat Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"100392","DOI":"10.1016\/j.obmed.2022.100392","article-title":"Metformin treatment ameliorates endocrine-metabolic disturbances in letrozole-induced PCOS mice model by modulating adiponectin status","volume":"31","author":"Ul haq Shah","year":"2022","journal-title":"Obes Med Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2641","article-title":"Clinical review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus","volume":"92","author":"Codner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2003.10.005","article-title":"Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease","volume":"35","author":"Kafali","year":"2004","journal-title":"Arch Med Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.922136","article-title":"A rat model of polycystic ovary syndrome with insulin resistance induced by letrozole combined with high fat diet","volume":"26","author":"Wang","year":"2020","journal-title":"Med Sci Monitor Int Med J Exp Clin Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome hum","volume":"11","author":"Abbott","year":"2005","journal-title":"Reprod Update"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/REP-15-0352","article-title":"Letrozole vsestradiolvalerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment","volume":"151","author":"Daneasa","year":"2016","journal-title":"Reproduction"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27144476","article-title":"Potential role of quercetin in polycystic ovary syndrome and its complications: a review","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/IJWH.S11304","article-title":"Treatment options for polycystic ovary syndrome","volume":"3","author":"Badawy","year":"2011","journal-title":"Int J Womens Health"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1071\/RD18222","article-title":"Amelioration by quercetin of insulin resistance and uterine GLUT4 and ER\u03b1 gene expression in rats with polycystic ovary syndrome (PCOS)","volume":"31","author":"Neisy","year":"2019","journal-title":"Reprod Fertil Dev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-0616-z","article-title":"Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review","volume":"13","author":"PourteymourFardTabrizi","year":"2020","journal-title":"J Ovarian Res"},{"key":"B13","article-title":"Yao xuexuebao","volume":"46","author":"Shu","year":"2011","journal-title":"ActapharmaceuticaSinica"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2021.08.015","article-title":"Mechanism of quercetin on the improvement of ovulation disorder and regulation of ovarian CNP\/NPR2 in PCOS model rats","volume":"121","author":"Zheng","year":"2022","journal-title":"J Formosan Med Assoc  Taiwan Yizhi"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-118705","article-title":"Effects of quercetin on adiponectin-mediated insulin sensitivity in polycystic ovary syndrome: a randomized placebo-controlled double-blind clinical trial","volume":"49","author":"Rezvan","year":"2017","journal-title":"Horm Metab Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2021.108936","article-title":"The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome","volume":"177","author":"Mahmoud","year":"2022","journal-title":"Steroids"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00580-023-03466-1","article-title":"The hypoglycemic and anti-hyperlipidemic activity of vitamin c in di(2-ethylhexyl) phthalate-induced toxicity in female mice, mus musculus","author":"Soni","year":"2023","journal-title":"Comp Clin Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100160","article-title":"Turmeric extract alleviates endocrine-metabolic disturbances in letrozole-induced PCOS by increasing adiponectin circulation: a comparison with metformin","volume":"13","author":"Shah","year":"2021","journal-title":"Metab Open"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079382","article-title":"Effects of electroacupuncture on ovarian P450arom, P450c17alpha and mRNA expression induced by letrozole in PCOS rats","volume":"8","author":"Sun","year":"2013","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.178833","article-title":"A novel method of extraction of bamboo seed oil (BambusabambosDruce) and its promising effect on metabolic symptoms of experimentally induced polycystic ovarian disease","volume":"48","author":"Soumya","year":"2016","journal-title":"Indian J Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jwh.2014.5000","article-title":"Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study","volume":"24","author":"Joham","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den263","article-title":"Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome","volume":"23","author":"Cussons","year":"2008","journal-title":"Hum Reprod"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope","year":"2009","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00580-023-03446-5","article-title":"Ameliorative effects of quercetin on endocrine and metabolic abnormalities associated with experimentally induced polycystic ovary syndrome in mice","author":"Shah","year":"2023","journal-title":"Comp Clin Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metabol: TEM"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.19080\/GJPPS.2018.06.555692","article-title":"A closer insight into the role of vitamin d in polycystic ovary syndrome (Pcos)","volume":"6","author":"El-bahya","year":"2018","journal-title":"Glob J Pharmaceu Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/14647270802621358","article-title":"Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF, hum","volume":"12","author":"Artini","year":"2009","journal-title":"Fertil"},{"key":"B28","doi-asserted-by":"publisher","first-page":"(1)","DOI":"10.1186\/1476-4598-12-7","article-title":"Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site, mol","volume":"12","author":"Eisermann","year":"2013","journal-title":"Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165636","article-title":"Analysis of VEGFA variants and changes in VEGF levels underscores the contribution of VEGF to polycystic ovary syndrome","volume":"11","author":"Almawi","year":"2016","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2020.74.289-293","article-title":"Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS) - obese vs. non- obese women","volume":"74","author":"Saadia","year":"2020","journal-title":"Med Arch (Sarajevo Bosnia Herzegovina)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome - a hypothesis","volume":"174","author":"Abbott","year":"2002","journal-title":"J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2012.01936.x","article-title":"Kami-shoyo-san, kampo (Japanese traditional medicine), is effective for climacteric syndrome, especially in hormone-replacement-therapy-resistant patients who strongly complain of psychological symptoms","volume":"39","author":"Hidaka","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2018.05.003","article-title":"Licorice ethanol extract improves symptoms of polycytic ovary syndrome in letrozole-induced female rats","volume":"7","author":"Yang","year":"2018","journal-title":"Integr Med Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2006.04.006\\","article-title":"Microscopic characterization of follicular structures in letrozoleinduced polycystic ovarian syndrome in the rat","volume":"37","author":"Baravalle","year":"2006","journal-title":"Arch Med Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-015-0139-1","article-title":"The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome","volume":"8","author":"Chen","year":"2015","journal-title":"J Ovarian Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3109\/13880209.2015.1091482","article-title":"Phosphatidylinositide 3-kinase inhibition: a new potential target for the treatment of polycystic ovarian syndrome","volume":"54","author":"Shah","year":"2016","journal-title":"Pharm Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318978111","article-title":"Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression","volume":"111","author":"Hammes","year":"2014","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010512","article-title":"EstradiolSignaling at the heart of folliculogenesis: its potential deregulation in human ovarian pathologies","volume":"23","author":"Chauvin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2017.07.002","article-title":"A regulatory role of androgen in ovarian steroidogenesis by rat granulosa cells","volume":"172","author":"Hasegawa","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1095\/biolreprod.110.085043","article-title":"Current concepts of follicle-stimulating hormone receptor gene regulation","volume":"84","author":"George","year":"2011","journal-title":"Biol Reprod"},{"key":"B42","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1210\/er.2009-0012","article-title":"The mammalian ovary from genesis to revelation.Endocr","volume":"30","author":"Edson","year":"2009","journal-title":"Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122093","article-title":"Advances on nanoformulation approaches for delivering plant-derived antioxidants: a case of quercetin","volume":"625","author":"Rathod","year":"2022","journal-title":"Int J Pharm"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1153289\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T15:45:25Z","timestamp":1692632725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1153289\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":43,"alternative-id":["10.3389\/fendo.2023.1153289"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1153289","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"article-number":"1153289"}}